showed that pancreatic cancer cells were characterized by a hypermutated landscape, with the KRAS oncogene, TP53, CDKN2A, and SMAD4 tumor suppressor genes the four most commonly mutated genes (14). This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.